N02AX02 tramadol
NERVOUS SYSTEM ›ANALGESICS ›OPIOIDS ›Other opioids
健保收載品項 TFDA 在效許可證 19 FDA 已核准 健保給付條款 1
台灣藥品與外觀
健保收載品名:"五洲" 妥美度 長效錠100毫克、"克能達" 舒敏長效錠劑、"南光" 立克痛注射液50毫克/毫升(鹽酸妥美度)、"南光" 立克痛膠囊50公絲(鹽酸妥美度)、"壽元" 斯眠靜注射液50公絲/公撮(鹽酸妥美度)、"寶齡" 舒痛膠囊50毫克(鹽酸妥美度)、"政德" 止痛能注射液50公絲/公撮(鹽酸妥美度)、"派頓" 頓痛特膠囊50毫克(鹽酸妥美度)。、"瑞士" 特美痛注射液50毫克/毫升(鹽酸妥美度)、"瑞士" 特美痛膠囊50毫克、"美時" 妙而通持續釋放錠100毫克(鹽酸妥美度)、〝克能達〞舒敏注射液、〝克能達〞舒敏膠囊、卡莫德膠囊50公絲、史達德妥滿多膠囊50毫克、得多注射液50毫克/毫升(妥美度)
無外觀照
鹽酸 妥美度
無外觀照
鹽酸妥美度
資料來源:食藥署「西藥許可證」+「藥品 ATC 碼」+「藥品外觀」+「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。
適應症
台灣 TFDA 核准適應症
- 嚴重之急、慢性疼痛。
- 中度至嚴重性之急慢性疼痛。
- 中度至嚴重性的急慢性疼痛。
- 中度至嚴重的急慢性疼痛。
- 嚴重之急慢性疼痛。
- 鎮痛劑。
- 鎮痛藥。
美國 FDA 適應症(英文原文對照)
1 INDICATIONS AND USAGE Tramadol hydrochloride and acetaminophen tablets are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use: Tramadol hydrochlorideandacetaminophen tablets are indicated for short-term use of five days or less. Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see Warnings and Precautions (5.1) ] , reserve tramadol hydrochloride and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): Have not been tolerated orare not expected to be tolerated, Have not provided adequate analgesia orare not expected to provide adequate analgesia. Tramadol hydrochloride and acetaminophen tablets should notbeused for an extended period of time. Tramadol hydrochloride and acetaminophen tablets are a combination of tramadol hydrochloride, an opioid agonist, and acetaminophen, and are indicated for the management of acute pain, severe enough to require an opioid analgesic and for which alternative treatments are inadequate. ( 1 ) Limitations of Use: ( 1 ) Tramadol hydrochloride and acetaminophen tablets are indicated for short-term use of five days or less. Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration, reserve tramadol hydrochloride and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): Have not been tolerated or are not expected to be tolerated Have not provided adequate analgesia or are not expected to provide adequate analgesia Tramadol hydrochloride and acetaminophen tablets should not be used for an extended period of time.
資料來源:食藥署西藥許可證適應症(中文)、openFDA US SPL(英文,僅供對照)。
健保給付規定
直接適用條款
§ 1.1.3 Tramadol (87/4/1)
神經系統藥物 › 疼痛解除劑
Tramadol (87/4/1) 限 1.癌症病例使用。 2.用於非癌症慢性頑固性疼痛(疼痛期超過六個月)之病人,需同時符合下述條件: (1)需為服用NSAIDs仍無法控制疼痛或有嚴重副作用者。 (2)需檢附疼痛評估報告,內容需包括疼痛強度及疼痛緩解的VAS與VRS (Visual Analogue Scale和Verbal Rating Scale)。
歷史演變(1 次異動)
| 生效日 | 異動說明 |
|---|---|
| 87/4/1 | legacy_boan_parsed:ch01.txt |
實證補充
本藥品尚無實證補充整理(未來新增 Review/指引知識時補列)。
台灣藥品與適應症:食藥署西藥許可證+ATC+外觀+仿單開放資料 · FDA:openFDA US SPL · 健保給付:健保署「全民健康保險藥品給付規定」(更新日 2026-06-09)· 實證補充:人工彙整。 本頁為資訊整理,實際給付與適應症以主管機關公告為準。